ClinicalTrials.gg
Not yet recruitingNCT07938788Updated Nov 16, 2026

Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism

An interventional study of Control Diet and Diverse Diet in Healthy and Overweight (BMI > 25), sponsored by University of Kiel. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by University of Kiel · Not applicable, Interventional, and Other

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 151 studies in Overweight with a site in Germany — 40 open to participants now, 62 under way, 34 of them phase 3. Overweight · Germany.

Planned enrollment
124th of 142
34 · median 131
Started
2027
with 1 other
No phase
53 of 151
11 open now
Primary completion
2029-09
later than 57 of 61 live
Registered
149th of 151
by date

Among the 151 studies in Overweight with a site in Germany, this one is the 124th largest by planned enrollment of the 142 interventional ones that give a count, is one of 2 that started in 2027, is one of 53 with no phase, reaches primary completion later than 57 of the 61 other live ones, and was the 149th registered.

Overweight

3,613 studies on the registry are indexed under Overweight; 856 are open to participants now.

Browse Overweight studies →

Open to participants now

40 of the 151 studies in Overweight with a site in Germany are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 531 Overweight studies recruiting now, 159 (30%) set no upper age limit and 344 (65%) stop at 75 or younger; 63 take children under 18; 205 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 151 studies in Overweight with a site in Germany, or all of them as a file.
02

Study summary

This randomized, controlled, crossover dietary intervention will test whether a three-week diverse diet, compared with a control diet with lower food diversity, changes postprandial insulin responses, other metabolic parameters, and the gut microbiome in 34 healthy adults with overweight. Participants will complete both diets in a randomized order, separated by a four-week washout period. The intervention periods will be conducted under free-living conditions, with study foods provided by the research center. Before and after each intervention period, postprandial metabolism will be assessed using standardized meal tests conducted under controlled whole-room calorimetry conditions. The primary outcome is the log-transformed total postprandial insulin area under the concentration-time curve from 0 to 240 minutes.

03

Conditions studied

  • Healthy
  • Overweight (BMI > 25)

Browse trials for

Keywords

  • Postprandial
  • Dietary diversity
  • Gut microbiome
  • Dietary fiber
  • Polyphenols
  • Fermented foods
  • ultra-processed foods
  • metabolic flexibility
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adults with overweight.
  • Age 18-60 years.
  • (BMI) >=25 and \<30 kg/m2.
  • Men and women; the study plans an equal distribution of biological sex.
  • No regular sports participation; regular sporting activity >=2 h/week is excluded.
  • German-speaking, because the study questionnaires are in German and not validated in other languages.
  • No anemia or iron deficiency based on screening and ferritin.
  • Women of must use hormonal (e.g., pill, hormonal IUD, contraceptive patch, vaginal ring, 3-month injection, or hormonal implant) and have pregnancy excluded by hCG testing.
  • Able and willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • - Individuals unable to provide informed written consent.
  • Vegetarian or vegan diet.
  • Habitual consumption of more than 5 caffeinated beverages per day.
  • Chronic diseases.
  • Regular medication use, except oral .
  • Antibiotic use within 6 weeks before study start.
  • Anemia and/or iron deficiency.
  • Pregnancy or breastfeeding.
  • Cigarette and/or cannabis use, including vaping.
  • Food allergies and/or food intolerances.
  • Current weight-reduction diet or weight loss >5 kg within the previous 3 months.
  • Regular sporting activity >=2 h/week.
  • Claustrophobia/fear of confined spaces because of EchoMRI assessment.
  • Active participation in another study.
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Control Diet -> Diverse Diet

    Other: Control Diet · Other: Diverse Diet

  • Experimental
    Diverse Diet -> Control Diet

    Other: Control Diet · Other: Diverse Diet

Interventions

  • OtherControl Diet

    Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet.

  • OtherDiverse Diet

    Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet.

06

What researchers measure

Primary outcomes

  1. Postprandial Insulin

    fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

    Time frame: 0-240 minutes

Secondary outcomes

  1. Postprandial Glucose

    fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

    Time frame: 0-240 minutes

  2. C-Peptide

    Urinary c-peptide excretion during the 24h stay in the whole-room indirect calorimeter.

    Time frame: 24 hours

  3. Non-esterified fatty acids

    fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

    Time frame: 0-240 minutes

  4. Triglycerides

    fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

    Time frame: 0-240 minutes

  5. Appetite-relatied hormones (GLP-1, PYY, Ghrelin)

    fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

    Time frame: 0-240 minutes

  6. Subjective Appetite

    measured with visual analogue scales (5 hours AUC; mm x 5 hours) after a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side.

    Time frame: 0-300 minutes

  7. Energy Expenditure and macronutrient oxidation

    measured during the 24h stay with indirect calorimetry in a whole-room indirect calorimeter (kcal/day) at the beginning and end of each three-week intervention period, i.e., twice per intervention.

    Time frame: 24 hours

  8. Gut microbiome composition and Microbiome diversity

    taxonomy and function via shotgun metagenome sequencing

    Time frame: Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.

07

Study locations

1 site
  • Institute of Human Nutrition and Food Science , Department Human Nutrition
    Kiel, Schleswig-Holstein 24105, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2027; primary completion for Sep 2029, 31 months later.

Of 1,305 non-industry interventional studies with no phase under Overweight, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 38. This study's planned 31 months is above that.

Counting every sponsor, half of 1,417 studies reached it within 17 months; a quarter within 8 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 19, 2026
First posted
Nov 16, 2026
StartEst.
Feb 1, 2027
Primary completionEst.
Sep 1, 2029
CompletionEst.
Jul 1, 2030
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07938788
Lead sponsor
University of Kiel
Responsible party
Prof. Dr. Dr. Anja Bosy-Westphal (Professor, University of Kiel) — Principal investigator
First posted
Nov 16, 2026
Start date
Feb 1, 2027 (estimated)
Primary completion
Sep 1, 2029 (estimated)
Completion
Jul 1, 2030 (estimated)
Last update
Nov 16, 2026

Study contacts

Anja Bosy-Westphal, Prof. Dr. Dr.
Contact
abosyw@nutrition.uni-kiel.de
+49 431 880 5674

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion